Navigation Links
Society of Interventional Radiology Names Marshall Hicks, M.D., FSIR, as 2012-13 President

SAN FRANCISCO, March 28, 2012 /PRNewswire-USNewswire/ -- Marshall Hicks, M.D., FSIR, an interventional radiologist and head of the division of diagnostic imaging at the University of Texas MD Anderson Cancer Center in Houston, assumed office as the 2012–13 president of the Society of Interventional Radiology during its 37th Annual Scientific Meeting in San Francisco, Calif. SIR is a national organization of nearly 5,000 scientists and allied health professionals dedicated to improving health care through minimally invasive treatments.


"The Society of Interventional Radiology is committed to developing—and demonstrating the value of—care-changing minimally invasive treatments to improve health care for patients in this era of evidence-based medicine," said Hicks, who is MD Anderson's Levit Family Distinguished Chair in Diagnostic Imaging and professor of vascular and interventional radiology. "Interventional radiologists are responsible for much of the medical innovation and advancement of minimally invasive treatments that are commonplace today. This year, we will continue to measure, document and communicate the value this specialty brings to health care administrators, to insurers, to legislators—and most importantly, to patients," he added.

Hicks received his medical degree from the University of Kentucky College of Medicine and completed a clinical internship in general surgery at Memorial University Medical Center in Savannah, Ga.  After his radiology residency and serving as an instructor in vascular radiology at Indiana University Medical Center in Indianapolis, he completed a clinical fellowship in interventional/vascular radiology at the University of Colorado Health Sciences Center in Denver. Hicks also served as an assistant professor and associate professor at the Mallinckrodt Institute of Radiology in St. Louis, Mo., before joining MD Anderson in 1998.

He is an active member of many professional organizations and his bibliography includes more than 100 papers and book chapters covering a wide variety of topics in radiologic oncology. Hicks has been listed in Best Doctors in America and is a recipient of an American Board of Radiology Lifetime Service Award.

More information about the Society of Interventional Radiology, interventional radiologists and how to find an interventional radiologist in your area can be found online at

About the Society of Interventional Radiology
Interventional radiologists are physicians who specialize in minimally invasive, targeted treatments. They offer the most in-depth knowledge of the least invasive treatments available coupled with diagnostic and clinical experience across all specialties. They use X-ray, MRI and other imaging to advance a catheter in the body, such as in an artery, to treat at the source of the disease internally. As the inventors of angioplasty and the catheter-delivered stent, which were first used in the legs to treat peripheral arterial disease, interventional radiologists pioneered minimally invasive modern medicine. Today, interventional oncology is a growing specialty area of interventional radiology. Interventional radiologists can deliver treatments for cancer directly to the tumor without significant side effects or damage to nearby normal tissue.

Many conditions that once required surgery can be treated less invasively by interventional radiologists. Interventional radiology treatments offer less risk, less pain and less recovery time compared to open surgery. Visit

The Society of Interventional Radiology is holding its 37th Annual Scientific Meeting March 24–29 at the Moscone Center (North) in San Francisco, Calif. The theme of the meeting is "IR Evidence," with the focus on gathering, presenting and discussing the results of relevant and care-changing investigations.



SOURCE Society of Interventional Radiology
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society
2. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
3. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
4. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
5. Stemline Therapeutics, Inc. Announces Two Poster Presentations of SL-401 Efficacy Data Against Lymphoid Cancers at the 53rd Annual Meeting of the American Society of Hematology (ASH)
6. Monsanto Declared Worst Company of 2011 by NaturalSociety
7. Elsevier Collaborates with the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)
8. A New Mechanism for Tau Protein Pathology in Alzheimers Disease was Presented by Oligomerix, Inc. at the Society for Neuroscience Annual Meeting
9. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
10. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
11. Quest Diagnostics Encourages Denver Area Residents to Enroll in Historic American Cancer Society Prevention Study November 8th - 19th
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... ... were featured on AngelList early in their initial angel funding process. Now, they ... for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be ... York on Wednesday, December 2 at 9:30 a.m. ET/6:30 ... CEO, will provide a corporate overview. th Annual ... 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola , ... corporate overview. --> th Annual Oppenheimer Healthcare Conference ...
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the ... the Toronto Stock Exchange, confirms that as of the ... developments that would cause the recent movements in the ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged in ...
(Date:11/24/2015)... , ... November 24, 2015 , ... The Academy of ... Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent the First–Person ... few years. Many AMA members have embraced this type of racing and several new ...
Breaking Biology Technology:
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
(Date:10/29/2015)... , Oct. 29, 2015  The J. Craig ... report titled, "DNA Synthesis and Biosecurity: Lessons Learned and ... Department of Health and Human Services guidance for synthetic ... 2010. --> --> ... also has the potential to pose unique biosecurity threats. ...
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
Breaking Biology News(10 mins):